DLHIX vs. IBNAX

Last updated Jun 4, 2026

DLHIX (Delaware Healthcare Fund) and IBNAX (Delaware Ivy Balanced Fund) are both mutual funds - DLHIX is a Health & Biotech Equities fund managed by Delaware Funds by Macquarie, while IBNAX is a Diversified Portfolio fund managed by Delaware Funds by Macquarie. Over the past 10 years, DLHIX returned 10.09%/yr vs 9.17%/yr for IBNAX. A 0.74 correlation means they provide meaningful diversification when combined. DLHIX charges 0.98%/yr vs 1.10%/yr for IBNAX.

Performance

DLHIX vs. IBNAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Delaware Healthcare Fund (DLHIX) and Delaware Ivy Balanced Fund (IBNAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DLHIX achieves a -4.36% return, which is significantly lower than IBNAX's 6.51% return. Over the past 10 years, DLHIX has outperformed IBNAX with an annualized return of 10.09%, while IBNAX has yielded a comparatively lower 9.17% annualized return.

DLHIX

• 1D: -2.28%
• 1M: -2.21%
• YTD: -4.36%
• 6M: -4.03%
• 1Y: 21.49%
• 3Y*: 11.04%
• 5Y*: 6.91%
• 10Y*: 10.09%

IBNAX

• 1D: 0.07%
• 1M: 2.22%
• YTD: 6.51%
• 6M: 6.20%
• 1Y: 16.43%
• 3Y*: 14.75%
• 5Y*: 7.32%
• 10Y*: 9.17%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DLHIX vs. IBNAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DLHIX Delaware Healthcare Fund	-4.36%	22.27%	8.76%	5.42%	-0.99%	5.48%	12.02%	31.82%	-0.59%	32.29%
IBNAX Delaware Ivy Balanced Fund	6.51%	12.17%	15.68%	16.19%	-16.41%	16.22%	14.34%	22.13%	-3.32%	11.37%

Correlation

The correlation between DLHIX and IBNAX is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.52
Correlation (5Y) Calculated over the trailing 5-year period	0.58
Correlation (10Y) Calculated over the trailing 10-year period	0.65
Correlation (All Time) Calculated using the full available price history since Oct 1, 2007	0.74

Over the past year, the correlation between DLHIX and IBNAX has dropped to 0.45 - well below their long-term average of 0.74, suggesting their price drivers have been diverging.

Return for Risk

DLHIX vs. IBNAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DLHIX

DLHIX Risk / Return Rank: 23
DLHIX Sharpe Ratio Rank: 20
DLHIX Sortino Ratio Rank: 21
DLHIX Omega Ratio Rank: 18
DLHIX Calmar Ratio Rank: 30
DLHIX Martin Ratio Rank: 25

IBNAX

IBNAX Risk / Return Rank: 41
IBNAX Sharpe Ratio Rank: 40
IBNAX Sortino Ratio Rank: 40
IBNAX Omega Ratio Rank: 40
IBNAX Calmar Ratio Rank: 37
IBNAX Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DLHIX vs. IBNAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Delaware Healthcare Fund (DLHIX) and Delaware Ivy Balanced Fund (IBNAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DLHIX	IBNAX	Difference
Sharpe ratio: Return per unit of total volatility	1.29	1.85	-0.57
Sortino ratio: Return per unit of downside risk	1.92	2.67	-0.75
Omega ratio: Gain probability vs. loss probability	1.22	1.34	-0.12
Calmar ratio: Return relative to maximum drawdown	2.06	2.28	-0.21
Martin ratio: Return relative to average drawdown	6.24	9.80	-3.56
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DLHIX vs. IBNAX - Sharpe Ratio Comparison

The current DLHIX Sharpe Ratio is 1.29, which is lower than the IBNAX Sharpe Ratio of 1.85. The chart below compares the historical Sharpe Ratios of DLHIX and IBNAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DLHIX	IBNAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.29	1.85	-0.57
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.44	0.37	+0.07
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.56	0.55	+0.01
Sharpe Ratio (All Time) Calculated using the full available price history	0.70	0.36	+0.34

Drawdowns

DLHIX vs. IBNAX - Drawdown Comparison

The maximum DLHIX drawdown since its inception was -34.64%, smaller than the maximum IBNAX drawdown of -52.04%. Use the drawdown chart below to compare losses from any high point for DLHIX and IBNAX.

Drawdown Indicators

	DLHIX	IBNAX	Difference
Max Drawdown Largest peak-to-trough decline	-34.64%	-52.04%	+17.40%
Max Drawdown (1Y) Largest decline over 1 year	-10.30%	-7.42%	-2.88%
Max Drawdown (3Y) Largest decline over 3 years	-19.79%	-10.91%	-8.88%
Max Drawdown (5Y) Largest decline over 5 years	-19.79%	-28.04%	+8.25%
Max Drawdown (10Y) Largest decline over 10 years	-25.60%	-28.04%	+2.44%
Current Drawdown Current decline from peak	-7.85%	-0.37%	-7.48%
Average Drawdown Average peak-to-trough decline	-5.56%	-10.48%	+4.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.39%	1.72%	+1.67%

Volatility

DLHIX vs. IBNAX - Volatility Comparison

Delaware Healthcare Fund (DLHIX) has a higher volatility of 4.73% compared to Delaware Ivy Balanced Fund (IBNAX) at 3.04%. This indicates that DLHIX's price experiences larger fluctuations and is considered to be riskier than IBNAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DLHIX	IBNAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.73%	3.04%	+1.69%
Volatility (6M) Calculated over the trailing 6-month period	11.97%	7.46%	+4.51%
Volatility (1Y) Calculated over the trailing 1-year period	16.50%	9.11%	+7.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.96%	20.09%	-4.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.93%	16.66%	+1.27%

DLHIX vs. IBNAX - Expense Ratio Comparison

DLHIX has a 0.98% expense ratio, which is lower than IBNAX's 1.10% expense ratio.

Dividends

DLHIX vs. IBNAX - Dividend Comparison

DLHIX's dividend yield for the trailing twelve months is around 11.66%, more than IBNAX's 2.91% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DLHIX Delaware Healthcare Fund	11.66%	11.16%	14.00%	6.97%	9.16%	5.41%	6.19%	7.63%	2.11%	3.23%	8.20%	7.90%
IBNAX Delaware Ivy Balanced Fund	2.91%	3.10%	1.86%	1.11%	26.49%	11.58%	6.76%	7.70%	11.85%	4.62%	2.31%	6.20%

Frequently Asked Questions

Can I hold both DLHIX and IBNAX in my portfolio?

DLHIX and IBNAX have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DLHIX or IBNAX?

DLHIX has higher volatility (4.73%) compared to IBNAX (3.04%). In terms of maximum drawdown, DLHIX dropped -34.64% vs IBNAX's -52.04%.

Which has better risk-adjusted returns?

IBNAX currently has the higher Sharpe Ratio (1.85 vs 1.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.